Table 1 Baseline patient characteristics.
Characteristic | Ganetespib (n = 93) | Control (n = 140) |
|---|---|---|
Median age (range), yr | 48 (26–73) | 48 (24–77) |
Ethnicity, n (%) | ||
White | 74 (80%) | 109 (78%) |
African American | 13 (14%) | 22 (16%) |
Asian | 6 (6%) | 7 (5%) |
Other/Mixed | 0 (0%) | 2 (1%) |
HR Status, n (%) | ||
Positive | 48 (52%) | 72 (51%) |
Negative | 45 (48%) | 68 (49%) |
MammaPrint Status, n (%) | ||
MP.Hi1 (MP1) | 32 (34%) | 76 (54%) |
MP.Hi2 (MP2) | 61 (66%) | 64 (46%) |
Median Tumor Size by MRI (range), cm | 3.8 (1.5–14) | 3.9 (1.2–15) |
Pretreatment SBR Grade | ||
I | 1 (1%) | 2 (1%) |
II | 10 (11%) | 30 (21%) |
III | 46 (49%) | 63 (45%) |
N/A | 36 (39%) | 45 (32%) |
Baseline node status, n (%) | ||
Palpable | 26 (28%) | 65 (46%) |
Non-palpable | 56 (60%) | 64 (46%) |
N/A | 11 (12%) | 11 (8%) |
